- Improvement of supportive systems for medically-underserved areas
-
Lim SM, Kim KH
- KMID: 2532140
- J Korean Med Assoc.
- 2022 Jul;65(7):449-459.
- doi: 10.5124/jkma.2022.65.7.449
Background: In order to encourage physicians to work in medically-underserved areas, it is imperative to provide financial incentives and appropriate supportive systems. This paper reviews the concept of medically-underserved areas... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between obesity and COVID-19
-
Lim S
- KMID: 2532137
- J Korean Med Assoc.
- 2022 Jul;65(7):423-429.
- doi: 10.5124/jkma.2022.65.7.423
Background: Since December 2019, most countries have struggled with the novel coronavirus, severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). During the coronavirus disease-2019 (COVID-19) pandemic, weight gain became prevalent because the preventive... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-pharmacologic treatment for obesity
-
Koo BK
- KMID: 2532134
- J Korean Med Assoc.
- 2022 Jul;65(7):400-407.
- doi: 10.5124/jkma.2022.65.7.400
Background: The prevalence of obesity has been rapidly increasing in the Korean population. Obesity is a well-known risk factor for various chronic diseases, including diabetes mellitus, hypertension, dyslipidemia, atherosclerosis, chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical treatment for obesity
-
Lee DY, Lee CM
- KMID: 2532136
- J Korean Med Assoc.
- 2022 Jul;65(7):417-422.
- doi: 10.5124/jkma.2022.65.7.417
Background: Bariatric or metabolic surgery is a safe and effective intervention for patients with obesity at higherrisk. In 2019, after the reimbursement in Korea, the number of metabolic surgery cases... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of obesity treatment in Korea:based on the 2020 Korean Society for the Study of Obesity guidelines for obesity management
-
Rhee EJ
- KMID: 2532132
- J Korean Med Assoc.
- 2022 Jul;65(7):388-392.
- doi: 10.5124/jkma.2022.65.7.388
Background: Obesity is a complex disease, and its prevalence is gradually increasing globally. The increasing prevalence of obesity is shown to significantly affect the development of obesity-related comorbidities. This paper... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacologic treatment of obesity
-
Jung HN, Jung CH
- KMID: 2532135
- J Korean Med Assoc.
- 2022 Jul;65(7):408-416.
- doi: 10.5124/jkma.2022.65.7.408
Background: Obesity and obesity-related comorbidities are increasingly being recognized as significant threats to global health. Pharmacological treatments are required in patients in whom lifestyle modifications fail to achieve an individual’s... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status and epidemiology of adult obesity in Korea
-
Nam GE
- KMID: 2532133
- J Korean Med Assoc.
- 2022 Jul;65(7):394-399.
- doi: 10.5124/jkma.2022.65.7.394
Background: Obesity has emerged as one of the most critical public health problems and is considered a global epidemic. Herein we summarized the recent epidemiology of obesity in Korean adults... -
- CITED
-
- Close
- SHARE
-
- Close
- Reperfusion therapy in acute ischemic stroke
-
Lee SH, Lee JH
- KMID: 2532138
- J Korean Med Assoc.
- 2022 Jul;65(7):430-439.
- doi: 10.5124/jkma.2022.65.7.430
Background: Until mid-2010, intravenous thrombolysis remains the only reperfusion therapy for acute ischemic stroke. In 2015, the five pivotal endovascular recanalization therapy (ERT) trials demonstrated that ERT improved the prognosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacotherapy for pulmonary embolism: new anticoagulants
-
Hwang HG, Kim YK
- KMID: 2532139
- J Korean Med Assoc.
- 2022 Jul;65(7):442-448.
- doi: 10.5124/jkma.2022.65.7.442
Background: Pulmonary embolism is associated with reduced survival and considerable economic burden worldwide. In Korea, the incidence of pulmonary embolism has been gradually increasing. Older individuals are at an increased... -
- CITED
-
- Close
- SHARE
-
- Close
